A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling

Jun Gui1, Yan Yue, Ruizhen Chen

  • 1Institute for Immunobiology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

Plos One
|October 3, 2012
PubMed

Insights

A20 protein protects against Coxsackievirus B3-induced myocarditis by reducing inflammation and inhibiting the NF-κB signaling pathway. This finding offers a potential new therapeutic strategy for viral myocarditis treatment.

Area of Science:

  • Cardiology
  • Virology
  • Immunology

Background:

  • Viral myocarditis, often caused by Coxsackievirus B3 (CVB3), involves cardiac inflammation.
  • Current therapies for inflammation in viral myocarditis are insufficient.
  • A20 (TNFAIP3) is a known negative regulator of inflammation, but its role in CVB3-induced myocarditis was unclear.

Purpose of the Study:

  • To investigate the protective effects of A20 against CVB3-induced myocarditis.
  • To elucidate the molecular mechanisms underlying A20's potential role.

Main Methods:

  • Established a mouse model of acute viral myocarditis via CVB3 inoculation.
  • Administered adenovirus expressing A20 (Ad-A20) intravenously.
  • Measured pro-inflammatory cytokine levels (TNF-α, IL-1β, IL-6, MCP-1).
  • Assessed the activity of the NF-κB signaling pathway and TRAF6 ubiquitylation.

Main Results:

  • CVB3 infection markedly increased pro-inflammatory cytokines, correlating with disease severity.
  • Ad-A20 treatment significantly reduced these cytokines and alleviated myocarditis severity.
  • A20 inhibited CVB3-induced NF-κB signaling.
  • A20 restricted TRAF6 ubiquitylation, thereby inhibiting NF-κB signaling.

Conclusions:

  • A20 demonstrates a protective role against CVB3-induced myocarditis.
  • A20 functions by inhibiting the NF-κB signaling pathway.
  • A20 represents a potential novel therapeutic strategy for viral myocarditis.
Abstract

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...